Clinical Trial Update: Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating irinotecan plus cisplatin in locally advanced or metastatic penile cancer has completed, with results reported in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Penile Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Irinotecan (Irinotecan)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Penile Cancer | Phase 2 | Status: COMPLETED